细胞性-话题@MedSci

#细胞性#

141篇内容 | 2982人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1805199, encodeId=b41a1805199d8, content=<a href='/topic/show?id=3138e790655' target=_blank style='color:#2F92EE;'>#细胞性#</a>, objectTitle=Nat Commun：NPM1突变的急性髓细胞性白血病独特亚型的生物学和治疗意义, objectType=article, longId=207669, objectId=0ed120e66987, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0ed120e66987, replyNumber=0, likeNumber=110, createdTime=2021-09-14, rootId=0, userName=lqrandywkz, userId=86b7385, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0ed120e66987, moduleTitle=Nat Commun：NPM1突变的急性髓细胞性白血病独特亚型的生物学和治疗意义, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0ed120e66987)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1805200, encodeId=b524180520001, content=<a href='/topic/show?id=3138e790655' target=_blank style='color:#2F92EE;'>#细胞性#</a>, objectTitle=JCO：转移性非精原细胞性生殖细胞肿瘤患者的预后预测, objectType=article, longId=209700, objectId=78d4209e0067, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=78d4209e0067, replyNumber=0, likeNumber=81, createdTime=2021-05-31, rootId=0, userName=lqrandywkz, userId=86b7385, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=78d4209e0067, moduleTitle=JCO：转移性非精原细胞性生殖细胞肿瘤患者的预后预测, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=78d4209e0067)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1805205, encodeId=9c96180520510, content=<a href='/topic/show?id=3138e790655' target=_blank style='color:#2F92EE;'>#细胞性#</a>, objectTitle=Clin Gastroenterology H: STAT6变异与接受长期质子泵抑制剂治疗的患者的嗜酸性粒细胞性食管炎复发有关, objectType=article, longId=217646, objectId=910c21e6469c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=910c21e6469c, replyNumber=0, likeNumber=134, createdTime=2021-10-09, rootId=0, userName=lqrandywkz, userId=86b7385, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=910c21e6469c, moduleTitle=Clin Gastroenterology H: STAT6变异与接受长期质子泵抑制剂治疗的患者的嗜酸性粒细胞性食管炎复发有关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=910c21e6469c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1805194, encodeId=a14118051942d, content=<a href='/topic/show?id=3138e790655' target=_blank style='color:#2F92EE;'>#细胞性#</a>, objectTitle=Venclyxto（venetoclax）治疗慢性淋巴细胞性白血病：已获NICE支持, objectType=article, longId=203281, objectId=a9322032812e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a9322032812e, replyNumber=0, likeNumber=66, createdTime=2021-02-10, rootId=0, userName=lqrandywkz, userId=86b7385, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a9322032812e, moduleTitle=Venclyxto（venetoclax）治疗慢性淋巴细胞性白血病：已获NICE支持, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a9322032812e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1805203, encodeId=13bd18052037a, content=<a href='/topic/show?id=3138e790655' target=_blank style='color:#2F92EE;'>#细胞性#</a>, objectTitle=J Clin Oncol：新诊断的小儿T淋巴细胞性淋巴瘤多药化疗的长期安全性和有效性结果公布（COG AALL0434研究）, objectType=article, longId=214041, objectId=ca9121404105, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ca9121404105, replyNumber=0, likeNumber=82, createdTime=2022-04-19, rootId=0, userName=lqrandywkz, userId=86b7385, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ca9121404105, moduleTitle=J Clin Oncol：新诊断的小儿T淋巴细胞性淋巴瘤多药化疗的长期安全性和有效性结果公布（COG AALL0434研究）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ca9121404105)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1805190, encodeId=5da71805190f2, content=<a href='/topic/show?id=3138e790655' target=_blank style='color:#2F92EE;'>#细胞性#</a>, objectTitle=BCL-2抑制剂Venclexta（venetoclax）获得FDA全面批准：用以治疗急性髓细胞性白血病（AML）, objectType=article, longId=202283, objectId=d69920228334, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d69920228334, replyNumber=0, likeNumber=83, createdTime=2021-04-30, rootId=0, userName=lqrandywkz, userId=86b7385, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d69920228334, moduleTitle=BCL-2抑制剂Venclexta（venetoclax）获得FDA全面批准：用以治疗急性髓细胞性白血病（AML）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d69920228334)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1805195, encodeId=34f2180519574, content=<a href='/topic/show?id=3138e790655' target=_blank style='color:#2F92EE;'>#细胞性#</a>, objectTitle=J Allergy Clin Immunol：研究确定ANO1在嗜酸粒细胞性食管炎中的治疗作用, objectType=article, longId=203351, objectId=80412033510b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=80412033510b, replyNumber=0, likeNumber=55, createdTime=2021-01-06, rootId=0, userName=lqrandywkz, userId=86b7385, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=80412033510b, moduleTitle=J Allergy Clin Immunol：研究确定ANO1在嗜酸粒细胞性食管炎中的治疗作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=80412033510b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1805193, encodeId=4660180519364, content=<a href='/topic/show?id=3138e790655' target=_blank style='color:#2F92EE;'>#细胞性#</a>, objectTitle=J Allergy Clin Immunol：基于组织和血液的平台可精准诊断嗜酸粒细胞性胃炎, objectType=article, longId=203234, objectId=7b402032344c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7b402032344c, replyNumber=0, likeNumber=0, createdTime=2021-01-16, rootId=0, userName=lqrandywkz, userId=86b7385, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7b402032344c, moduleTitle=J Allergy Clin Immunol：基于组织和血液的平台可精准诊断嗜酸粒细胞性胃炎, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7b402032344c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1805201, encodeId=d5c118052015a, content=<a href='/topic/show?id=3138e790655' target=_blank style='color:#2F92EE;'>#细胞性#</a>, objectTitle=Stroke：镰状细胞性贫血患者脑血流动力学与执行功能的关系, objectType=article, longId=210891, objectId=b88d210891e7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b88d210891e7, replyNumber=0, likeNumber=114, createdTime=2022-01-25, rootId=0, userName=lqrandywkz, userId=86b7385, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b88d210891e7, moduleTitle=Stroke：镰状细胞性贫血患者脑血流动力学与执行功能的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b88d210891e7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1805192, encodeId=672f18051928c, content=<a href='/topic/show?id=3138e790655' target=_blank style='color:#2F92EE;'>#细胞性#</a>, objectTitle=Gastroenterology：杜匹鲁单抗可有效治疗嗜酸粒细胞性食管炎, objectType=article, longId=203233, objectId=9e5220323392, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9e5220323392, replyNumber=0, likeNumber=82, createdTime=2021-08-26, rootId=0, userName=lqrandywkz, userId=86b7385, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9e5220323392, moduleTitle=Gastroenterology：杜匹鲁单抗可有效治疗嗜酸粒细胞性食管炎, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9e5220323392)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1805196, encodeId=427b1805196f0, content=<a href='/topic/show?id=3138e790655' target=_blank style='color:#2F92EE;'>#细胞性#</a>, objectTitle=Br J Cancer：IRS-1介导ER+乳腺癌中PR驱动的干细胞性和内分泌抗性, objectType=article, longId=203364, objectId=8909203364df, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8909203364df, replyNumber=0, likeNumber=83, createdTime=2021-06-11, rootId=0, userName=lqrandywkz, userId=86b7385, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8909203364df, moduleTitle=Br J Cancer：IRS-1介导ER+乳腺癌中PR驱动的干细胞性和内分泌抗性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8909203364df)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1805189, encodeId=4b4e180518961, content=<a href='/topic/show?id=3138e790655' target=_blank style='color:#2F92EE;'>#细胞性#</a>, objectTitle=ESID 2020：敏感性分析证实了Emapalumab治疗噬血细胞性淋巴组织细胞增多症（HLH）的功效, objectType=article, longId=202282, objectId=8ace202282a7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8ace202282a7, replyNumber=0, likeNumber=65, createdTime=2020-12-22, rootId=0, userName=lqrandywkz, userId=86b7385, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8ace202282a7, moduleTitle=ESID 2020：敏感性分析证实了Emapalumab治疗噬血细胞性淋巴组织细胞增多症（HLH）的功效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8ace202282a7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1805198, encodeId=57e9180519836, content=<a href='/topic/show?id=3138e790655' target=_blank style='color:#2F92EE;'>#细胞性#</a>, objectTitle=Cell Death Differ：非典型NF-κB信号转导通路影响慢性淋巴细胞性白血病的耐药性, objectType=article, longId=206400, objectId=1f6b206400f1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1f6b206400f1, replyNumber=0, likeNumber=69, createdTime=2022-01-01, rootId=0, userName=lqrandywkz, userId=86b7385, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1f6b206400f1, moduleTitle=Cell Death Differ：非典型NF-κB信号转导通路影响慢性淋巴细胞性白血病的耐药性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1f6b206400f1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1805191, encodeId=197d180519118, content=<a href='/topic/show?id=3138e790655' target=_blank style='color:#2F92EE;'>#细胞性#</a>, objectTitle=METTL3抑制剂sTC-15治疗急性髓细胞性白血病, objectType=article, longId=202472, objectId=052f2024e20c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=052f2024e20c, replyNumber=0, likeNumber=85, createdTime=2021-08-12, rootId=0, userName=lqrandywkz, userId=86b7385, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=052f2024e20c, moduleTitle=METTL3抑制剂sTC-15治疗急性髓细胞性白血病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=052f2024e20c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1805185, encodeId=fcc5180518551, content=<a href='/topic/show?id=3138e790655' target=_blank style='color:#2F92EE;'>#细胞性#</a>, objectTitle=加拿大批准BCL-2抑制剂VENCLEXTA与CD20单抗Obinutuzumab联合，用于先前未治疗的慢性淋巴细胞性白血病患者, objectType=article, longId=193606, objectId=c7931936061f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c7931936061f, replyNumber=0, likeNumber=71, createdTime=2021-04-03, rootId=0, userName=lqrandywkz, userId=86b7385, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c7931936061f, moduleTitle=加拿大批准BCL-2抑制剂VENCLEXTA与CD20单抗Obinutuzumab联合，用于先前未治疗的慢性淋巴细胞性白血病患者, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c7931936061f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1805197, encodeId=3f0d180519e4a, content=<a href='/topic/show?id=3138e790655' target=_blank style='color:#2F92EE;'>#细胞性#</a>, objectTitle=Blood：IL-18介导镰状细胞性心肌病和室性心动过速的发生, objectType=article, longId=204378, objectId=e8dd2043e8be, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e8dd2043e8be, replyNumber=0, likeNumber=89, createdTime=2021-11-14, rootId=0, userName=lqrandywkz, userId=86b7385, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e8dd2043e8be, moduleTitle=Blood：IL-18介导镰状细胞性心肌病和室性心动过速的发生, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e8dd2043e8be)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1805187, encodeId=e289180518ef3, content=<a href='/topic/show?id=3138e790655' target=_blank style='color:#2F92EE;'>#细胞性#</a>, objectTitle=FDA批准Onureg（azacitidine）治疗急性髓细胞性白血病（AML）, objectType=article, longId=200392, objectId=7b192003927b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7b192003927b, replyNumber=0, likeNumber=87, createdTime=2021-02-27, rootId=0, userName=lqrandywkz, userId=86b7385, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7b192003927b, moduleTitle=FDA批准Onureg（azacitidine）治疗急性髓细胞性白血病（AML）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7b192003927b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1805188, encodeId=fe1e180518879, content=<a href='/topic/show?id=3138e790655' target=_blank style='color:#2F92EE;'>#细胞性#</a>, objectTitle=FDA授予Bcl-2抑制剂APG-2575孤儿药资格，用于治疗慢性淋巴细胞性白血病, objectType=article, longId=200404, objectId=d860200404a6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d860200404a6, replyNumber=0, likeNumber=70, createdTime=2021-06-04, rootId=0, userName=lqrandywkz, userId=86b7385, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d860200404a6, moduleTitle=FDA授予Bcl-2抑制剂APG-2575孤儿药资格，用于治疗慢性淋巴细胞性白血病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d860200404a6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1805186, encodeId=20c7180518611, content=<a href='/topic/show?id=3138e790655' target=_blank style='color:#2F92EE;'>#细胞性#</a>, objectTitle=NEJM：Emapalumab治疗原发性噬血细胞性淋巴组织细胞增多症, objectType=article, longId=193715, objectId=511c193e15ce, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=511c193e15ce, replyNumber=0, likeNumber=79, createdTime=2021-02-27, rootId=0, userName=lqrandywkz, userId=86b7385, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=511c193e15ce, moduleTitle=NEJM：Emapalumab治疗原发性噬血细胞性淋巴组织细胞增多症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=511c193e15ce)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1805176, encodeId=033118051e6db, content=<a href='/topic/show?id=3138e790655' target=_blank style='color:#2F92EE;'>#细胞性#</a>, objectTitle=误诊为生殖器疱疹的浆细胞性龟头炎1 例, objectType=article, longId=180626, objectId=3b4218062672, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3b4218062672, replyNumber=0, likeNumber=71, createdTime=2020-07-22, rootId=0, userName=lqrandywkz, userId=86b7385, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3b4218062672, moduleTitle=误诊为生殖器疱疹的浆细胞性龟头炎1 例, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3b4218062672)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

细胞性

2020-05-29

lqrandywkz (审核中...)

前往app查看评论内容

#细胞性#

Nat Commun：NPM1突变的急性髓细胞性白血病独特亚型的生物学和治疗意义

2021-09-14

lqrandywkz (审核中...)

前往app查看评论内容

#细胞性#

JCO：转移性非精原细胞性生殖细胞肿瘤患者的预后预测

2021-05-31

lqrandywkz (审核中...)

前往app查看评论内容

#细胞性#

Clin Gastroenterology H: STAT6变异与接受长期质子泵抑制剂治疗的患者的嗜酸性粒细胞性食管炎复发有关

2021-10-09

lqrandywkz (审核中...)

前往app查看评论内容

#细胞性#

Venclyxto（venetoclax）治疗慢性淋巴细胞性白血病：已获NICE支持

2021-02-10

lqrandywkz (审核中...)

前往app查看评论内容

#细胞性#

J Clin Oncol：新诊断的小儿T淋巴细胞性淋巴瘤多药化疗的长期安全性和有效性结果公布（COG AALL0434研究）

2022-04-19

lqrandywkz (审核中...)

前往app查看评论内容

#细胞性#

BCL-2抑制剂Venclexta（venetoclax）获得FDA全面批准：用以治疗急性髓细胞性白血病（AML）

2021-04-30

lqrandywkz (审核中...)

前往app查看评论内容

#细胞性#

J Allergy Clin Immunol：研究确定ANO1在嗜酸粒细胞性食管炎中的治疗作用

2021-01-06

lqrandywkz (审核中...)

前往app查看评论内容

#细胞性#

J Allergy Clin Immunol：基于组织和血液的平台可精准诊断嗜酸粒细胞性胃炎

2021-01-16

lqrandywkz (审核中...)

前往app查看评论内容

#细胞性#

Stroke：镰状细胞性贫血患者脑血流动力学与执行功能的关系

2022-01-25

lqrandywkz (审核中...)

前往app查看评论内容

#细胞性#

Gastroenterology：杜匹鲁单抗可有效治疗嗜酸粒细胞性食管炎

2021-08-26

lqrandywkz (审核中...)

前往app查看评论内容

#细胞性#

Br J Cancer：IRS-1介导ER+乳腺癌中PR驱动的干细胞性和内分泌抗性

2021-06-11

lqrandywkz (审核中...)

前往app查看评论内容

#细胞性#

ESID 2020：敏感性分析证实了Emapalumab治疗噬血细胞性淋巴组织细胞增多症（HLH）的功效

2020-12-22

lqrandywkz (审核中...)

前往app查看评论内容

#细胞性#

Cell Death Differ：非典型NF-κB信号转导通路影响慢性淋巴细胞性白血病的耐药性

2022-01-01

lqrandywkz (审核中...)

前往app查看评论内容

#细胞性#

METTL3抑制剂sTC-15治疗急性髓细胞性白血病

2021-08-12

lqrandywkz (审核中...)

前往app查看评论内容

#细胞性#

加拿大批准BCL-2抑制剂VENCLEXTA与CD20单抗Obinutuzumab联合，用于先前未治疗的慢性淋巴细胞性白血病患者

2021-04-03

lqrandywkz (审核中...)

前往app查看评论内容

#细胞性#

Blood：IL-18介导镰状细胞性心肌病和室性心动过速的发生

2021-11-14

lqrandywkz (审核中...)

前往app查看评论内容

#细胞性#

FDA批准Onureg（azacitidine）治疗急性髓细胞性白血病（AML）

2021-02-27

lqrandywkz (审核中...)

前往app查看评论内容

#细胞性#

FDA授予Bcl-2抑制剂APG-2575孤儿药资格，用于治疗慢性淋巴细胞性白血病

2021-06-04

lqrandywkz (审核中...)

前往app查看评论内容

#细胞性#

NEJM：Emapalumab治疗原发性噬血细胞性淋巴组织细胞增多症

2021-02-27

lqrandywkz (审核中...)

前往app查看评论内容

#细胞性#

误诊为生殖器疱疹的浆细胞性龟头炎1 例

2020-07-22

科室
- - 订阅+
  - 更多科室
工具
服务